Abstract:Genitourinary problems, including neurogenic dysfunction, impotence, prostatism, urinary tract infections, and prostate cancer, are common in the elderly, and most of the symptoms can be alleviated through pharmacological management.Patients with neurogenic dysfunction who present with symptoms such as incontinence and urinary retention can be appropriately managed with bladder and sphincter relaxants or stimulants. Anticholinergic agents in the form of oxybutynin, flavoxate, and propantheline are effective bladder relaxants, and phenoxybenzamine, prazosin, and terazosin are commonly used as sphincter relaxants. Bethanechol chloride is the agent most commonly used to stimulate bladder contraction, but physicians should be careful when prescribing it for elderly patients with cardiovascular problems.Organic and psychogenic causes of impotence usually overlap, and oral agents have limited use in the treatment process. The use of yohimbine has increased recently, but its value and rate of success remains questionable. Testosterone is being used widely to treat impotence, but it is only helpful to patients with hypogonadism and should be used with discretion in the elderly, who have a high incidence of prostate cancer. Vasoactive intracavernous pharmacotherapy, on the other hand, is a recently discovered alternative to testosterone with promising results.Although the treatment of choice for benign prostatic hypertrophy is surgery, there have been important pharmacological advances in treating this disorder. α-Adrenergic antagonists and antiandrogenic agents have been found to relieve the symptoms of prostatic enlargement.The use of chemotherapeutic and antibiotic agents to treat and suppress acute and chronic urinary tract infections is reviewed; these are second only to pulmonary infections as the most frequent cause of febrile episodes in patients over the age of 65. Lower urinary tract infections can be treated with almost any antibacterial agent. Upper urinary tract infections require full genitourinary evaluation and appropriate antibiotics should be used according to the urine culture sensitivity studies.With the advent of new hormonal agents, more choices are now available for the management of prostate cancer, which is the second most common malignancy in men. Diethylstilbestrol (stilboestrol), an oral estrogen, remains a commonly used agent to achieve castrate levels of androgens in advanced prostatic carcinoma. Agonist analogues, such as goserelin and leuprorelin, of gonadotrophin-releasing hormone (GnRH) [luteinising hormone-releasing hormone (LHRH); or gonadorelin] achieve the same results as diethylstilbestrol but without the cardiovascular side effects. Antiandrogens are also being used in combination with GnRH agonists to produce complete androgen blockage, with mixed results.

Acute Urinary Retention in a Patient With Heart Failure and Benign Prostatic Hyperplasia: A Case Report

The Evaluation and Management of Acute Urinary Retention in Elderly Male patients

Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management

Urinary Retention in Adults: Evaluation and Initial Management

Urethral Calculus as an Uncommon Cause of Acute Urinary Retention in Women Diagnosis and Management: A Case Report

Characteristics of recurrent acute urinary retention in BPH patients in the United States: Retrospective analysis of US-based insurance claims database

Current Concepts in the Treatment of Genitourinary Tract Disorders in the Older Individual

[Management of geriatric patients with benign prostatic hyperplasia]

A retrospection of 1345 cases of inpatients with Benign prostatic hyperplasia in the past 10 years

Acute urinary retention: causes, risk of complications, treatment methods (literature review)

Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia

Acute urinary retention from hyperangulation of the urinary bladder neck secondary to uterine leiomyoma, a case report

Surgical Outcomes for Elderly Patients Undergoing Transurethral Resection of the Prostate for Chronic Urinary Retention and Proposal of a Management Algorithm

Acute Urinary Retention and Severe Hyponatremia in a Patient With a Large Intramural Uterine Fibroid

Urology case report: Multifactorial bladder dysfunction in the setting of down syndrome

Acute urinary retention in men: 21‐year trends in incidence, subsequent benign prostatic hyperplasia‐related treatment and mortality: A Danish population‐based cohort study

Pharmacological Relief of Acute Urinary Retention in a Remote Environment

Correlation of Benign Prostatic Hyperplasia Diagnosed on Transabdominal Ultrasound with Urinary Retention Checked with Post Micturition Residual Volume on Ultrasound

Acute urinary tract infection in patients with underlying benign prostatic hyperplasia and prostate cancer

A Case of Asymptomatic Massive Inguinoscrotal Bladder in Acute Renal Failure

Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction